| Year |
Citation |
Score |
| 2020 |
Beeraka NM, Doreswamy SH, Sadhu SP, Srinivasan A, Pragada RR, Madhunapantula SV, Aliev G. The Role of Exosomes in Stemness and Neurodegenerative Diseases-Chemoresistant-Cancer Therapeutics and Phytochemicals. International Journal of Molecular Sciences. 21. PMID 32957534 DOI: 10.3390/ijms21186818 |
0.328 |
|
| 2020 |
Muresanu C, Somasundaram SG, Vissarionov SV, Torres Solis LF, Solís Herrera A, Kirkland CE, Aliev G. Updated Understanding of Cancer as a Metabolic and Telomere-Driven Disease, and Proposal for Complex Personalized Treatment, a Hypothesis. International Journal of Molecular Sciences. 21. PMID 32906638 DOI: 10.3390/ijms21186521 |
0.369 |
|
| 2020 |
Leszek J, Mikhaylenko EV, Belousov DM, Koutsouraki E, Szczechowiak K, Kobusiak-Prokopowicz M, Mysiak A, Diniz BS, Somasundaram SG, Kirkland CE, Aliev G. The Links between Cardiovascular Diseases and Alzheimer's Disease. Current Neuropharmacology. PMID 32727331 DOI: 10.2174/1570159X18666200729093724 |
0.45 |
|
| 2020 |
Chrishtop VV, Tomilova IK, Rumyantseva TA, Mikhaylenko EV, Avila-Rodriguez MF, Mikhaleva LM, Nikolenko VN, Somasundaram SG, Kirkland CE, Bachurin SO, Aliev G. The Effect of Short-Term Physical Activity on the Oxidative Stress in Rats with Different Stress Resistance Profiles in Cerebral Hypoperfusion. Molecular Neurobiology. PMID 32458388 DOI: 10.1007/s12035-020-01930-5 |
0.343 |
|
| 2020 |
Belousov DM, Mikhaylenko EV, Chubarev VN, Tarasov VV, Somasundaram SG, Kirkland CE, Aliev G. The Dawn of Mitophagy: What Do We Know by Now? Current Neuropharmacology. PMID 32442087 DOI: 10.2174/1570159X18666200522202319 |
0.357 |
|
| 2020 |
Mikhaleva LM, Davydov AI, Patsap OI, Mikhaylenko EV, Nikolenko VN, Neganova ME, Klochkov SG, Somasundaram SG, Kirkland CE, Aliev G. Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review. Advances in Therapy. PMID 32385745 DOI: 10.1007/s12325-020-01363-5 |
0.307 |
|
| 2019 |
Nikolenko VN, Oganesyan MV, Vovkogon AD, Nikitina AT, Sozonova EA, Kudryashova VA, Rizaeva NA, Cabezas R, Avila-Rodriguez M, Neganova ME, Mikhaleva LM, Bachurin SO, Somasundaram SG, Kirkland CE, Tarasov VV, ... Aliev G, et al. Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases. Current Neuropharmacology. PMID 31729299 DOI: 10.2174/1570159X17666191113103850 |
0.397 |
|
| 2019 |
Muresanu C, Somasundaram SG, Neganova ME, Bovina EV, Vissarionov SV, Ofodile ONFC, Fisenko VP, Bragin V, Minyaeva NN, Chubarev VN, Klochkov SG, Tarasov VV, Kirkland CE, Aliev G. Updated Understanding of the Degenerative Disc Diseases - Causes versus Effects - Treatments, Studies and Hypothesis. Current Topics in Medicinal Chemistry. PMID 31724500 DOI: 10.2174/1568026619666191114113048 |
0.339 |
|
| 2019 |
Aliev G, Li Y, Chubarev VN, Lebedeva SA, Parshina LN, Trofimov BA, Sologova SS, Makhmutova A, Avila-Rodriguez MF, Klochkov SG, Galenko-Yaroshevsky PA, Tarasov VV. Application of Acyzol in the Context of Zinc Deficiency and Perspectives. International Journal of Molecular Sciences. 20. PMID 31035445 DOI: 10.3390/Ijms20092104 |
0.304 |
|
| 2019 |
Bachurin SO, Makhaeva GF, Shevtsova EF, Boltneva NP, Kovaleva NV, Lushchekina SV, Rudakova EV, Dubova LG, Vinogradova DV, Sokolov VB, Aksinenko AY, Fisenko VP, Richardson RJ, Aliev G. Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases. Scientific Reports. 9: 4873. PMID 30890752 DOI: 10.1038/S41598-019-41272-4 |
0.321 |
|
| 2018 |
Ashraf GM, Tarasov VV, Makhmutovа A, Chubarev VN, Avila-Rodriguez M, Bachurin SO, Aliev G. The Possibility of an Infectious Etiology of Alzheimer Disease. Molecular Neurobiology. PMID 30338482 DOI: 10.1007/s12035-018-1388-y |
0.412 |
|
| 2018 |
Aliev G, Ashraf GM, Tarasov VV, Chubarev VN, Leszek J, Gasiorowski K, Makhmutovа A, Baeesa SS, Avila-Rodriguez M, Ustyugov AA, Bachurin SO. Alzheimer Disease - Future Therapy Based on Dendrimers. Current Neuropharmacology. PMID 30227819 DOI: 10.2174/1570159X16666180918164623 |
0.468 |
|
| 2018 |
Areiza-Mazo N, Robles J, Zamudio-Rodriguez JA, Giraldez L, Echeverria V, Barrera-Bailon B, Aliev G, Sahebkar A, Ashraf GM, Barreto GE. Extracts of Protect Astrocytic Cells Under Oxidative Stress With Rotenone. Frontiers in Chemistry. 6: 276. PMID 30175092 DOI: 10.3389/fchem.2018.00276 |
0.382 |
|
| 2018 |
Carrera I, Fernandez-Novoa L, Sampedro C, Cacabelos R, Aliev G. Dopaminergic neuroprotection with Atremorine in Parkinson´s disease. Current Medicinal Chemistry. PMID 29637853 DOI: 10.2174/0929867325666180410100559 |
0.321 |
|
| 2018 |
Bachurin SO, Gavrilova SI, Samsonova A, Barreto GE, Aliev G. Corrigendum to "Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention" [Pharmacol. Res. 129 (2018) 216-226]. Pharmacological Research. PMID 29555151 DOI: 10.1016/j.phrs.2018.03.006 |
0.343 |
|
| 2018 |
Baez-Jurado E, Vega GG, Aliev G, Tarasov VV, Esquinas P, Echeverria V, Barreto GE. Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay. Molecular Neurobiology. 55: 2285-2300. PMID 28332151 DOI: 10.1007/s12035-017-0481-y |
0.312 |
|
| 2018 |
Aliev G. Implication of the multitarget therapies in the context of the aged associated oxidative stress induced cellular and subcellular hypoperfusion and mitochondrial DNA deletion during the development and maturation of Alzheimer disease: Past present future Journal of Neurological Disorders. 6. DOI: 10.4172/2329-6895-c4-033 |
0.38 |
|
| 2017 |
Kosenko EA, Tikhonova LA, Montoliu C, Barreto GE, Aliev G, Kaminsky YG. Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease. Frontiers in Neuroscience. 11: 728. PMID 29354027 DOI: 10.3389/fnins.2017.00728 |
0.477 |
|
| 2017 |
Bachurin SO, Gavrilova SI, Samsonova A, Barreto GE, Aliev G. Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention. Pharmacological Research. PMID 29170097 DOI: 10.1016/j.phrs.2017.11.021 |
0.41 |
|
| 2017 |
Kosenko EA, Tikhonova LA, Alilova GA, Montoliu C, Barreto GE, Aliev G, Kaminsky YG. Portacaval shunting causes differential mitochondrial superoxide production in brain regions. Free Radical Biology & Medicine. PMID 28964916 DOI: 10.1016/j.freeradbiomed.2017.09.023 |
0.344 |
|
| 2017 |
Raevsky OA, Mukhametov A, Grigorev VY, Ustyugov A, Tsay SC, Jih-Ru Hwu R, Yarla NS, Barreto GE, Aliev G, Bachurin SO. Applications of Multi-Target Computer-Aided Methodologies in Molecular Design of CNS Drugs. Current Medicinal Chemistry. PMID 28933295 DOI: 10.2174/0929867324666170920154111 |
0.31 |
|
| 2017 |
Svistunov AA, Tarasov VV, Shakhmardanova SA, Sologova SS, Bagaturija ET, Chubarev VN, Galenko-Yaroshevsky PA, Barreto GE, Aliev G. Urotensin II: Molecular Mechanisms of Biological Activity. Current Protein & Peptide Science. PMID 28875851 DOI: 10.2174/1389203718666170829162335 |
0.311 |
|
| 2017 |
Martin-Jiménez CA, García-Vega Á, Cabezas R, Aliev G, Echeverria V, González J, Barreto GE. Astrocytes and endoplasmic reticulum stress: A bridge between obesity and neurodegenerative diseases. Progress in Neurobiology. 158: 45-68. PMID 28802884 DOI: 10.1016/j.pneurobio.2017.08.001 |
0.357 |
|
| 2017 |
Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, Giri PV, Kumar N, Malla R, Chari VB, Reddy D RS, Bade R, Mannarapu M, Barretto G, Lu DY, Tarasov VV, ... ... Aliev G, et al. Anthocyanins: Possible role as Multitarget therapeutic agents for prevention and therapy of chronic diseases. Current Pharmaceutical Design. PMID 28741457 DOI: 10.2174/1381612823666170519151801 |
0.501 |
|
| 2017 |
Shevtsova EF, Vinogradova D, Neganova ME, Avila-Rodriguez M, Ashraf GMd, Barreto GE, Bachurin SO, Aliev G. Mitochondrial Permeability Transition Pore as a Suitable Target for Neuroprotective Agents Against Alzheimer Disease. Cns & Neurological Disorders Drug Targets. PMID 28440192 DOI: 10.2174/1871527316666170424114444 |
0.388 |
|
| 2017 |
Sawikr Y, Yarla NS, Peluso I, Kamal MA, Aliev G, Bishayee A. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals. Advances in Protein Chemistry and Structural Biology. 108: 33-57. PMID 28427563 DOI: 10.1016/bs.apcsb.2017.02.001 |
0.46 |
|
| 2017 |
Bachurin SO, Shevtsova EF, Makhaeva GF, Grigoriev VV, Boltneva NP, Kovaleva NV, Lushchekina SV, Shevtsov PN, Neganova ME, Redkozubova OM, Bovina EV, Gabrelyan AV, Fisenko VP, Sokolov VB, Aksinenko AY, ... ... Aliev G, et al. Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment. Scientific Reports. 7: 45627. PMID 28358144 DOI: 10.1038/srep45627 |
0.332 |
|
| 2017 |
Echeverria V, Barreto GE, Avila-Rodriguezc M, Tarasov VV, Aliev G. Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease? Current Alzheimer Research. 14: 1155-1163. PMID 28356047 DOI: 10.2174/1567205014666170329113007 |
0.355 |
|
| 2017 |
Mazo NA, Echeverria V, Cabezas R, Avila-Rodriguez M, Tarasov VV, Yarla NS, Aliev G, Barreto GE. Medicinal Plants as Protective Strategies Against Parkinson's Disease. Current Pharmaceutical Design. 23: 4180-4188. PMID 28302024 DOI: 10.2174/1381612823666170316142803 |
0.446 |
|
| 2017 |
Leszek J, Tse WH, Zhang J, Ávila-Rodriguez MF, Tarasov VV, Barreto GE, Bachurin SO, Aliev G. Nanotechnology for Alzheimer Disease. Current Alzheimer Research. PMID 28164767 DOI: 10.2174/1567205014666170203125008 |
0.385 |
|
| 2017 |
Volcho KP, Laev SS, Ashraf GM, Aliev G, Salakhutdinov NF. Application of monoterpenoids and their derivatives for treatment of neurodegenerative disorders. Current Medicinal Chemistry. PMID 28079000 DOI: 10.2174/0929867324666170112101837 |
0.401 |
|
| 2017 |
Gąsiorowski K, Brokos B, Leszek J, Ashraf GM, Aliev G. Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players. Current Topics in Medicinal Chemistry. PMID 28049397 DOI: 10.2174/1568026617666170103161233 |
0.359 |
|
| 2017 |
Leszek J, Trypka E, Tarasov VV, Md Ashraf G, Aliev G. Type 3 Diabetes Mellitus: A Novel Implication of Alzheimer Disease. Current Topics in Medicinal Chemistry. PMID 28049395 DOI: 10.2174/1568026617666170103163403 |
0.342 |
|
| 2017 |
Herrera AS, Solis-Arias MP, V. Tarasov V, Md Ashraf G, Aliev G. Alopecia Areata and Medical Modulation of the Intrinsic Property of Melanin to Transform Light Into Chemical Energy Through the Water Dissociation Archives of Clinical and Biomedical Research. 1: 125-131. DOI: 10.26502/acbr.50170016 |
0.325 |
|
| 2016 |
Neganova ME, Klochkov SG, Petrova LN, Shevtsova E, Afanasieva SV, Chudinova ES, Fisenko VP, Bachurin SO, Barreto GE, Aliev G. Securinine derivatives as potential anti-amyloid therapeutic approach. Cns & Neurological Disorders Drug Targets. PMID 27823572 DOI: 10.2174/1871527315666161107090525 |
0.419 |
|
| 2016 |
Ustyugov A, Shevtsova E, Barreto GE, Ashraf GM, Bachurin SO, Aliev G. New therapeutic property of Dimebon as a neuroprotective agent. Current Medicinal Chemistry. PMID 27494393 DOI: 10.2174/0929867323666160804122746 |
0.4 |
|
| 2016 |
Cacabelos R, Reddy VP, Aliev G. Editorial: Neurodegeneration, Oxidative Stress, Metabolic Syndrome, Drug Design and Development: Clinical Implications. Cns & Neurological Disorders Drug Targets. 15: 126. PMID 26907796 DOI: 10.2174/187152731502160215131206 |
0.312 |
|
| 2016 |
Cacabelos R, Torrellas C, Carrera I, Cacabelos P, Corzo L, Fernández-Novoa L, Tellado I, Carril JC, Aliev G. Novel Therapeutic Strategies for Dementia. Cns & Neurological Disorders Drug Targets. PMID 26831267 DOI: 10.2174/1871527315666160202121548 |
0.416 |
|
| 2016 |
Chibber S, Alexiou A, Alama MN, Barreto GE, Aliev G, Ashraf GM. A synopsis on the linkage between age-related dementias and vascular disorders. Cns & Neurological Disorders Drug Targets. PMID 26831266 DOI: 10.2174/1871527315666160202121809 |
0.366 |
|
| 2016 |
Lanussa OH, Ávila-Rodriguez M, García-Segura LM, González J, Echeverria V, Aliev G, Barreto GE. Microglial dependent protective effects of neuroactive steroids. Cns & Neurological Disorders Drug Targets. 15: 242-9. PMID 26831265 DOI: 10.2174/1871527315666160202122032 |
0.315 |
|
| 2016 |
Khan TA, Hassan I, Ahmad A, Perveen A, Aman S, Quddusi S, Alhazza IM, Ashraf GM, Aliev G. Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders. Cns & Neurological Disorders Drug Targets. PMID 26831262 DOI: 10.2174/1871527315666160202124518 |
0.396 |
|
| 2016 |
Jurado-Coronel JC, Ávila-Rodriguez M, Echeverria V, Hidalgo OA, Gonzalez J, Aliev G, Barreto GE. Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease. Cns & Neurological Disorders Drug Targets. 15: 292-300. PMID 26831259 DOI: 10.2174/1871527315666160202125519 |
0.337 |
|
| 2016 |
Leszek J, Barreto GE, Gąsiorowski K, Koutsouraki E, Ávila-Rodrigues M, Aliev G. Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System. Cns & Neurological Disorders Drug Targets. PMID 26831258 DOI: 10.2174/1871527315666160202125914 |
0.417 |
|
| 2016 |
Garzón D, Cabezas R, Vega N, Ávila-Rodriguez M, Gonzalez J, Gómez RM, Echeverria V, Aliev G, Barreto GE. Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches. Journal of Molecular Neuroscience : Mn. 58: 483-92. PMID 26803310 DOI: 10.1007/s12031-016-0719-6 |
0.364 |
|
| 2016 |
Echeverria V, Yarkov A, Aliev G. Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease. Progress in Neurobiology. 144: 142-57. PMID 26797042 DOI: 10.1016/j.pneurobio.2016.01.002 |
0.44 |
|
| 2015 |
Cacabelos R, Torrellas C, Fernández-Novoa L, Aliev G. Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection. Current Pharmaceutical Design. PMID 26648474 DOI: 10.2174/1381612822666151209150954 |
0.328 |
|
| 2015 |
González-Reyes RE, Aliev G, Ávila-Rodrigues M, Barreto GE. Alterations in glucose metabolism on cognition: A possible link between Diabetes and Dementia. Current Pharmaceutical Design. PMID 26648470 DOI: 10.2174/1381612822666151209152013 |
0.374 |
|
| 2015 |
Carrera I, Fernandez-Novoa L, Aliev G, Vigo C, Cacabelos R. Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine. Current Pharmaceutical Design. PMID 26648469 DOI: 10.2174/1381612822666151209152204 |
0.343 |
|
| 2015 |
Aliev G, Daza J, Herrera AS, del Carmen Arias Esparza M, Morales L, Echeverria V, Bachurin SO, Barreto GE. Nanoparticles as Alternative Strategies for Drug Delivery to the Alzheimer Brain: Electron Microscopy Ultrastructural Analysis. Cns & Neurological Disorders Drug Targets. 14: 1235-42. PMID 26295828 DOI: 10.2174/1871527314666150821102631 |
0.313 |
|
| 2015 |
Kosenko EA, Aliev G, Kaminsky YG. Relationship between chronic disturbance of 2,3-diphosphoglycerate metabolism in erythrocytes and Alzheimer disease. Cns & Neurological Disorders Drug Targets. PMID 26295825 DOI: 10.2174/1871527314666150821103444 |
0.451 |
|
| 2015 |
Neganova ME, Klochkov SG, Afanasieva SV, Serkova TP, Chudinova ES, Bachurin SO, Reddy VP, Aliev G, Shevtsova EF. Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound. Cns & Neurological Disorders Drug Targets. PMID 26295814 |
0.417 |
|
| 2015 |
Makhaeva GF, Lushchekina SV, Boltneva NP, Sokolov VB, Grigoriev VV, Serebryakova OG, Vikhareva EA, Aksinenko AY, Barreto GE, Aliev G, Bachurin SO. Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease. Scientific Reports. 5: 13164. PMID 26281952 DOI: 10.1038/srep13164 |
0.326 |
|
| 2015 |
Blach-Olszewska Z, Zaczynska E, Gustaw-Rothenberg K, Avila-Rodrigues M, Barreto GE, Leszek J, Aliev G. The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy. Current Pharmaceutical Design. 21: 3582-8. PMID 26166611 DOI: 10.2174/1381612821666150710144829 |
0.352 |
|
| 2015 |
Siew Hua G, Kamal MA, Lima MM, Khalil MI, Pasupuleti VR, Aliev G. Medicinal plants in management of type 2 diabetes and neurodegenerative disorders. Evidence-Based Complementary and Alternative Medicine : Ecam. 2015: 686872. PMID 25873981 DOI: 10.1155/2015/686872 |
0.341 |
|
| 2014 |
Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R, Ashraf GM, Jabir NR, Kamal MA, Nikolenko VN, Zamyatnin AA, Benberin VV, Bachurin SO. Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Current Medicinal Chemistry. 21: 2208-17. PMID 24372221 DOI: 10.2174/0929867321666131227161303 |
0.517 |
|
| 2014 |
Aliev G, Shahida K, Gan SH, Firoz C, Khan A, Abuzenadah AM, Kamal W, Kamal MA, Tan Y, Qu X, Reale M. Alzheimer disease and type 2 diabetes mellitus: the link to tyrosine hydroxylase and probable nutritional strategies. Cns & Neurological Disorders Drug Targets. 13: 467-77. PMID 24059309 DOI: 10.2174/18715273113126660153 |
0.459 |
|
| 2014 |
Kosenko EA, Solomadin IN, Tikhonova LA, Reddy VP, Aliev G, Kaminsky YG. Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and erythrocyte energy metabolism. Cns & Neurological Disorders Drug Targets. 13: 112-9. PMID 24040810 DOI: 10.2174/18715273113126660130 |
0.457 |
|
| 2013 |
Carrera I, Etcheverria I, Li Y, Fernandez-Novoa L, Lombardi V, Vigo C, Palacios HH, Benberin VV, Cacabelos R, Aliev G. Immunocytochemical Characterization of Alzheimer's Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid- Vaccine. Central Asian Journal of Global Health. 2: 119. PMID 29805876 DOI: 10.5195/Cajgh.2013.119 |
0.42 |
|
| 2013 |
Kaminsky YG, Reddy VP, Ashraf GM, Ahmad A, Benberin VV, Kosenko EA, Aliev G. Age-related defects in erythrocyte 2,3-diphosphoglycerate metabolism in dementia. Aging and Disease. 4: 244-55. PMID 24124630 DOI: 10.14336/AD.2013.0400244 |
0.393 |
|
| 2013 |
Carrera I, EtcheverrÃa I, Li Y, Fernández-Novoa L, Lombardi V, Vigo C, Palacios HH, Benberin VV, Cacabelos R, Aliev G. Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine. Biomed Research International. 2013: 709145. PMID 24089686 DOI: 10.1155/2013/709145 |
0.391 |
|
| 2013 |
Aliev G, Ashraf GM, Kaminsky YG, Sheikh IA, Sudakov SK, Yakhno NN, Benberin VV, Bachurin SO. Implication of the nutritional and nonnutritional factors in the context of preservation of cognitive performance in patients with dementia/depression and Alzheimer disease. American Journal of Alzheimer's Disease and Other Dementias. 28: 660-70. PMID 24085255 DOI: 10.1177/1533317513504614 |
0.392 |
|
| 2013 |
Aliev G, Obrenovich ME, Tabrez S, Jabir NR, Reddy VP, Li Y, Burnstock G, Cacabelos R, Kamal MA. Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion. Oxidative Medicine and Cellular Longevity. 2013: 962984. PMID 23691268 DOI: 10.1155/2013/962984 |
0.59 |
|
| 2013 |
Aliev G, Solís-Herrera A, Li Y, Kaminsky YG, Yakhno NN, Nikolenko VN, Zamyatnin Jr. AA, Benberin VV, Bachurin SO. Human photosynthesis, the ultimate answer to the long term mystery of Kleiber’s law or E = M<sup>3/4</sup>: Implication in the context of gerontology and neurodegenerative diseases Open Journal of Psychiatry. 3: 408-421. DOI: 10.4236/Ojpsych.2013.34045 |
0.301 |
|
| 2013 |
Aliev G, Bragin I, Bragin V. P3-036: Role of mitochondria-specific antioxidants and their derivatives in drug discovery and development for Alzheimer's disease Alzheimer's & Dementia. 9: P562-P563. DOI: 10.1016/j.jalz.2013.05.1105 |
0.444 |
|
| 2013 |
Aliev G. The role of oxidative stress, mitochondria failure, and cellular hypoperfusion in the context of alzheimer disease: Past, present and future The Role of Oxidative Stress, Mitochondria Failure, and Cellular Hypoperfusion in the Context of Alzheimer Disease: Past, Present and Future. 1-426. |
0.405 |
|
| 2012 |
Kosenko EA, Aliev G, Tikhonova LA, Li Y, Poghosyan AC, Kaminsky YG. Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers. Cns & Neurological Disorders Drug Targets. 11: 926-32. PMID 22998137 DOI: 10.2174/1871527311201070926 |
0.462 |
|
| 2012 |
Zhu X, Castellani RJ, Moreira PI, Aliev G, Shenk JC, Siedlak SL, Harris PL, Fujioka H, Sayre LM, Szweda PA, Szweda LI, Smith MA, Perry G. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radical Biology & Medicine. 52: 699-704. PMID 22137893 DOI: 10.1016/J.Freeradbiomed.2011.11.004 |
0.816 |
|
| 2012 |
Kaminsky Y, Poghosyan A, Tikhonova L, Palacios HH, Kamal MA, Kosenko E, Aliev G. Glycolytic and Proteolytic Metabolism in Erythrocytes from Elderly and Demented Patients American Journal of Neuroprotection and Neuroregeneration. 4: 73-77. DOI: 10.1166/AJNN.2012.1039 |
0.363 |
|
| 2012 |
Aliev G, Obrenovich M, Bragin V. P2-128: Mitochondrion-dependent oxidative stress in the context of neurodegeneration and cancer: Recent advance Alzheimer's & Dementia. 8: P305-P305. DOI: 10.1016/j.jalz.2012.05.833 |
0.442 |
|
| 2012 |
Aliev G, Li Y, Palacios HH, Obrenovich ME, Bragin V, Bragin I, Shevtsova E, Klochkov SG, Kosenko EA, Cacabelos R, Kaminsky YG, Bachurin SO, Benberin VV. Oxidative stress-induced mitochondrial damage as a hallmark for drug development in the context of the neurodegeneration, cardiovascular, and cerebrovascular diseases Systems Biology of Free Radicals and Antioxidants. 2083-2126. DOI: 10.1007/978-3-642-30018-9_208 |
0.36 |
|
| 2012 |
Aliev G, Horecký J, Vančová O, Ashraf GM, Hassan I, Bragin V, Bragin I, Shevtsova E, Klochkov SG, Kosenko EA, Cacabelos R, Bachurin SO, Benberin VV, Kaminsky YG. The three-vessel occlusion as a model of vascular dementia - Oxidative stress and mitochondrial failure as an indicator of brain hypoperfusion Systems Biology of Free Radicals and Antioxidants. 2023-2032. DOI: 10.1007/978-3-642-30018-9_205 |
0.306 |
|
| 2012 |
Aliev G, Li Y, Palacios HH, Obrenovich ME, Bragin V, Bragin I, Shevtsova E, Klochkov SG, Kosenko EA, Kaminsky YG, Bachurin SO, Cacabelos R. Atherosclerotic lesions and mitochondrial dna deletions as a primary hallmark of the brain microcirculation - Implication in the pathogenesis of Alzheimer's disease Systems Biology of Free Radicals and Antioxidants. 2127-2145. DOI: 10.1007/978-3-642-30018-9_203 |
0.328 |
|
| 2011 |
Aliev G, Li Y, Palacios HH, Obrenovich ME. Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases. Recent Patents On Cardiovascular Drug Discovery. 6: 222-41. PMID 21906026 DOI: 10.2174/157489011797376942 |
0.533 |
|
| 2011 |
Horecký J, Gvozdjáková A, Kucharská J, Obrenovich ME, Palacios HH, Li Y, VanÄová O, Aliev G. Effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion. Current Alzheimer Research. 8: 868-75. PMID 21592049 DOI: 10.2174/156720511798192727 |
0.342 |
|
| 2011 |
Obrenovich ME, Li Y, Parvathaneni K, Yendluri BB, Palacios HH, Leszek J, Aliev G. Antioxidants in health, disease and aging. Cns & Neurological Disorders Drug Targets. 10: 192-207. PMID 21226664 DOI: 10.2174/187152711794480375 |
0.402 |
|
| 2011 |
Gasiorowski K, Lamer-Zarawska E, Leszek J, Parvathaneni K, Yendluri BB, BÅ‚ach-Olszewska Z, Aliev G. Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration? Cns & Neurological Disorders Drug Targets. 10: 184-91. PMID 21222632 DOI: 10.2174/187152711794480384 |
0.383 |
|
| 2011 |
Palacios HH, Yendluri BB, Parvathaneni K, Shadlinski VB, Obrenovich ME, Leszek J, Gokhman D, GÄ…siorowski K, Bragin V, Aliev G. Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease. Cns & Neurological Disorders Drug Targets. 10: 149-62. PMID 21222631 DOI: 10.2174/187152711794480474 |
0.518 |
|
| 2011 |
Aliev G. Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. Cns & Neurological Disorders Drug Targets. 10: 147-8. PMID 21222630 DOI: 10.2174/187152711794480492 |
0.463 |
|
| 2011 |
Aliev G, Gasiorowski K, Palacios H, Gokhman D, Shadlinski V, Bragin V, Leszek J. O2-07-07: Oxidative stress-induced mitochondrial DNA overproliferation and deletion, cellular hypoperfusion and brain hypometabolism in the context of Alzheimer's disease: past, present and future Alzheimer's & Dementia. 7: S305-S305. DOI: 10.1016/j.jalz.2011.05.887 |
0.492 |
|
| 2011 |
Aliev G, Palacios HH, Obrenovich ME, Gokhman D, Gasiorowski K, Bragin V, Herrera AS. Oxidative stress induced vascular hypoperfusion, mitochondrial failure are missing links for the development of Alzheimer disease Vascular Dementia: Risk Factors, Diagnosis and Treatment. 49-78. |
0.404 |
|
| 2011 |
Aliev G, Palacios HH, Bhushan BY, Gasiorowski K, Gokhman D, Shadlinski VB, Bragin V, Leszek J. Oxidative stress-induced mitochondrial DNA overproliferation and deletion, cellular hypoperfusion and brain hypometabolism in the context of cerebrovascular and Alzheimer disease: Offer new and successful targets for the drug delivering and treatment | Nadmierny rozrost i zanik mitochondrialnego DNA spowodowane stresem tlenowym,zmniejszeniem perfuzji i metabolizmu tkanki mózgowej w chorobie naczyniowej mózgu i alzheimera: Nowa oferta skutecznej terapii Psychogeriatria Polska. 8: 23-30. |
0.329 |
|
| 2010 |
Aliev G, Palacios HH, Gasimov E, Obrenovich ME, Morales L, Leszek J, Bragin V, Solís Herrera A, Gokhman D. Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease. Pharmaceuticals (Basel, Switzerland). 3: 158-187. PMID 27713247 DOI: 10.3390/Ph3010158 |
0.517 |
|
| 2010 |
Obrenovich ME, Nair NG, Beyaz A, Aliev G, Reddy VP. The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Research. 13: 631-43. PMID 20818981 DOI: 10.1089/Rej.2010.1043 |
0.378 |
|
| 2010 |
VanÄová O, BaÄiak L, KaÅ¡parová S, Kucharská J, Palacios HH, Horecký J, Aliev G. In vivo and in vitro assessment of brain bioenergetics in aging rats. Journal of Cellular and Molecular Medicine. 14: 2667-74. PMID 19906014 DOI: 10.1111/j.1582-4934.2009.00879.x |
0.37 |
|
| 2010 |
Aliev G, Palacios HH, Gasimov E, Obrenovich ME, Morales L, Leszek J, Bragin V, Herrera AS, Gokhman D. Oxidative stress induced mitochondrial failure and vascular hypoperfusion as a key initiator for the development of alzheimer disease Pharmaceuticals. 3: 158-187. DOI: 10.3390/ph3010158 |
0.406 |
|
| 2010 |
Castellani R, Moreira P, Aliev G, Shenk J, Siedlak S, Harris P, Sayre L, Szweda L, Zhu X, Smith M, Perry G, Szweda P. Hydroxynonenal-Generated Crosslinking Fluorophore and Mitochondria-derived Lipoic Acid Accumulation in Alzheimer Disease Reveal a Dichotomy of Protein Turnover Microscopy and Microanalysis. 16: 1014-1015. DOI: 10.1017/S1431927610059350 |
0.811 |
|
| 2010 |
Shenk JC, Smith MA, Castellani RJ, Moreira P, Aliev G, Siedlak SL, Harris PL, Sayre L, Szweda PA, Szweda LI, Perry G. P1-196: Lipid peroxidation markers are associated with granulovacuolar degeneration but not lipofuscin formation Alzheimer's & Dementia. 6: S230-S230. DOI: 10.1016/J.Jalz.2010.05.746 |
0.764 |
|
| 2010 |
Palacios HH, Aliev G. O4-01-02: Mitochondria antioxidants as treatment strategies for Alzheimer' disease Alzheimer's & Dementia. 6: S150-S150. DOI: 10.1016/j.jalz.2010.05.466 |
0.311 |
|
| 2010 |
Aliev G, Palacios HH, Gasimov E, Gokhman D, Leszek J, Morales L, Obrenovich ME, Bragin V, Herrera AS. P3-440: Oxidative stress-induced mitochondrial failure and brain hypometabolism underlay the pathophysiology of Alzheimer's disease and offer target for treatment: Astonishing effect of melanin and mitochondrial antioxidants Alzheimer's & Dementia. 6: S582-S582. DOI: 10.1016/J.Jalz.2010.05.1982 |
0.386 |
|
| 2010 |
Aliev G, Palacios HH, Gasimov E, Gokhman D, Leszek J, Obrenovich ME, Bragin V, Herrera AS. P3-430: Targeting oxidative stress-induced brain hypometabolism and brain mitochondrial failure as new and effective strategies for the prevention and treatment of cognitive decline in elderly demented/depressed patients and those with Alzheimer's disease Alzheimer's & Dementia. 6: S579-S579. DOI: 10.1016/J.Jalz.2010.05.1973 |
0.326 |
|
| 2009 |
Obrenovich ME, Palacios HH, Gasimov E, Leszek J, Aliev G. The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease. Cardiovascular Psychiatry and Neurology. 2009: 327360. PMID 20204079 DOI: 10.1155/2009/327360 |
0.335 |
|
| 2009 |
Aliev G, Palacios HH, Walrafen B, Lipsitt AE, Obrenovich ME, Morales L. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. The International Journal of Biochemistry & Cell Biology. 41: 1989-2004. PMID 19703659 DOI: 10.1016/J.Biocel.2009.03.015 |
0.536 |
|
| 2009 |
Aliev G, Palacios HH, Lipsitt AE, Fischbach K, Lamb BT, Obrenovich ME, Morales L, Gasimov E, Bragin V. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotoxicity Research. 16: 293-305. PMID 19526276 DOI: 10.1007/S12640-009-9066-5 |
0.338 |
|
| 2009 |
Shenk JC, Liu J, Fischbach K, Xu K, Puchowicz M, Obrenovich ME, Gasimov E, Alvarez LM, Ames BN, Lamanna JC, Aliev G. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. Journal of the Neurological Sciences. 283: 199-206. PMID 19342064 DOI: 10.1016/J.Jns.2009.03.002 |
0.773 |
|
| 2009 |
Obrenovich ME, Morales LA, Cobb CJ, Shenk JC, Méndez GM, Fischbach K, Smith MA, Qasimov EK, Perry G, Aliev G. Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation. Journal of Cellular and Molecular Medicine. 13: 853-65. PMID 19292735 DOI: 10.1111/J.1582-4934.2008.00512.X |
0.817 |
|
| 2009 |
Horecký J, Baciak L, Kasparová S, Pacheco G, Aliev G, Vancová O. Minimally invasive surgical approach for three-vessel occlusion as a model of vascular dementia in the rat-brain bioenergetics assay. Journal of the Neurological Sciences. 283: 178-81. PMID 19272617 DOI: 10.1016/j.jns.2009.02.348 |
0.38 |
|
| 2009 |
Aliev G, Liu J, Shenk JC, Fischbach K, Pacheco GJ, Chen SG, Obrenovich ME, Ward WF, Richardson AG, Smith MA, Gasimov E, Perry G, Ames BN. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. Journal of Cellular and Molecular Medicine. 13: 320-33. PMID 18373733 DOI: 10.1111/J.1582-4934.2008.00324.X |
0.797 |
|
| 2009 |
Aliev G, Shenk J, Liu J, Puchowicz M, Xu K, Smith M, Siedlak S, Obrenovich M, Ames B, de la Torre J, Koistinaho J, LaManna J, Perry G. Preventative effect of mitochondrial antioxidants in apoe deficiency mouse model of brain hypoperfusion Journal of the Neurological Sciences. 283: 272. DOI: 10.1016/J.Jns.2009.02.126 |
0.797 |
|
| 2009 |
Perry G, Ames B, Aliev G. Is oxidative stress an initiator of mitochondrial failure and vascular hypoperfusion during aging and Alzheimer disease? Present and future Journal of the Neurological Sciences. 283: 270-271. DOI: 10.1016/J.Jns.2009.02.122 |
0.656 |
|
| 2009 |
Shenk JC, Castellani RJ, Moreira P, Aliev G, Siedlak SL, Harris PL, Sayre L, Szweda PA, Smith MA, Perry G. P2-186: Hydroxynonenal generated crosslinking fluorophores accumulate in Alzheimer's disease Alzheimer's & Dementia. 5: P315-P315. DOI: 10.1016/J.Jalz.2009.04.498 |
0.818 |
|
| 2009 |
Aliev G, Palacios HH, Pacheco GJ, Gasimov E, Morales L, Gokhman D, Obrenovich ME, Bragin V, Soils A, Leszek J. Oxidative stress induced mitochondrial failure and cellular hypoperfusion: Implication in the pathogenesis of Alzheimer disease Psychogeriatria Polska. 6: 155-179. |
0.419 |
|
| 2008 |
Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, Zhu X, Smith MA, Perry G. Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Reviews in Medicinal Chemistry. 8: 1395-406. PMID 18991755 DOI: 10.2174/138955708786369582 |
0.823 |
|
| 2008 |
Aliev G, Gasimov E, Obrenovich ME, Fischbach K, Shenk JC, Smith MA, Perry G. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vascular Health and Risk Management. 4: 721-30. PMID 18827923 DOI: 10.2147/Vhrm.S2608 |
0.83 |
|
| 2008 |
Aliev G, Shenk JC, Fischbach K, Perry G. Stem cell niches as clinical targets: the future of anti-ischemic therapy? Nature Clinical Practice. Cardiovascular Medicine. 5: 590-1. PMID 18628773 DOI: 10.1038/ncpcardio1295 |
0.764 |
|
| 2008 |
Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, Smith MA, Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radical Biology & Medicine. 44: 1493-505. PMID 18258207 DOI: 10.1016/J.Freeradbiomed.2008.01.002 |
0.833 |
|
| 2008 |
Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 4: 151-75. PMID 18188003 DOI: 10.4161/Auto.5338 |
0.64 |
|
| 2008 |
Aliev G, Liu J, Puchowicz M, Xu K, Siedlak S, Obrenovich M, Shenk J, Smith M, Gasimov E, LaManna J, Ames B, Perry G. DOES THE OXIDATIVE STRESS AND CEREBRAL ATHEROSCLEROSIS INITIATE BRAIN HYPOPERFUSION AND THE DEVELOPMENT OF ALZHEIMER DISEASE? Atherosclerosis Supplements. 9: 154. DOI: 10.1016/S1567-5688(08)70622-6 |
0.82 |
|
| 2008 |
Moreira PI, Santos MS, Siedlak SL, Harris P, Smith MA, Aliev G, Perry G, Oliveira CR. P4-185: Mitochondrial dysfunction in Alzheimer's disease Alzheimer's & Dementia. 4: T725-T725. DOI: 10.1016/J.Jalz.2008.05.2252 |
0.753 |
|
| 2008 |
Aliev G, Shenk JC, Fischbach K, Cobb CJ, Pacheco GJ, Gasimov E, Perry G. P4-171: Cerebral hypoperfusion-induced oxidative stress and mitochondrial failure as initiators of aging and Alzheimer's disease pathology Alzheimer's & Dementia. 4: T721-T721. DOI: 10.1016/j.jalz.2008.05.2238 |
0.835 |
|
| 2007 |
Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy. 3: 614-5. PMID 17786024 DOI: 10.4161/Auto.4872 |
0.853 |
|
| 2007 |
Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 66: 525-32. PMID 17549012 DOI: 10.1016/J.Jns.2009.02.162 |
0.836 |
|
| 2007 |
Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, Casadesus G, Harris PL, Siedlak SL, Perry G. Vascular oxidative stress in Alzheimer disease. Journal of the Neurological Sciences. 257: 240-6. PMID 17337008 DOI: 10.1016/J.Jns.2007.01.039 |
0.844 |
|
| 2007 |
Perry G, Moreira PI, Siedlak SL, Santos MS, Oliveira CR, Fujioka H, Tabaton M, Nunomura A, Aliev G, Szweda LI, Smith MA. Mitochondrial autophagocytosis in Alzheimer disease Journal of Neuropathology and Experimental Neurology. 66: 434. DOI: 10.1097/01.Jnen.0000268871.37441.1B |
0.834 |
|
| 2007 |
Perry G, Moreira PI, Siedlak SL, Santos MS, Oliveira CR, Fujioka H, Tabaton M, Nunomura A, Aliev G, Szweda LI, Smith MA. Mitochondrial Autophagocytosis in Alzheimer Disease The Faseb Journal. 21. DOI: 10.1096/fasebj.21.5.a73-c |
0.789 |
|
| 2007 |
Aliev G, Perry G, Shenk J, Puchowicz M, Xu K, Siedlak S, Obrenovich M, Smith M, Friedland R, Chen S, Ames B, Liu J, DeLaTore J, LaManna J, Koistinaho J. PO13-357 THE PRIMARY PATHOGENETIC ROLE OF VASCULAR HYPOPERFUSION, AND OXIDATIVE STRESS IN ALZHEIMER DISEASE Atherosclerosis Supplements. 8: 105. DOI: 10.1016/S1567-5688(07)71367-3 |
0.834 |
|
| 2007 |
Moreira PI, Nunomura A, Honda K, Aliev G, Casadesus G, Zhu X, Smith MA, Perry G. The key role of oxidative stress in alzheimer's disease Oxidative Stress and Neurodegenerative Disorders. 267-281. DOI: 10.1016/B978-044452809-4/50153-8 |
0.833 |
|
| 2006 |
Aliev G, Miller JP, Leifer DW, Obrenovich ME, Shenk JC, Smith MA, Lamanna JC, Perry G, Lust DW, Cohen AR. Ultrastructural analysis of a murine model of congenital hydrocephalus produced by overexpression of transforming growth factor-beta1 in the central nervous system. Journal of Submicroscopic Cytology and Pathology. 38: 85-91. PMID 17784635 |
0.712 |
|
| 2006 |
Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G, Aliev G. Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotoxicity Research. 10: 43-56. PMID 17000469 DOI: 10.1007/Bf03033333 |
0.65 |
|
| 2006 |
Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith MA. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. Journal of Alzheimer's Disease : Jad. 9: 147-53. PMID 16873962 DOI: 10.3233/JAD-2006-9207 |
0.824 |
|
| 2006 |
Moreira PI, Siedlak SL, Santos MS, Oliveira CR, Fujioka H, Tabaton M, Nunomura A, Aliev G, Szweda LI, Zhu X, Smith MA, Perry G. O4-02-08: Mitochondrial autophagocytosis in Alzheimer disease Alzheimer's & Dementia. 2: S79-S79. DOI: 10.1016/J.Jalz.2006.05.307 |
0.817 |
|
| 2005 |
Moreira PI, Honda K, Liu Q, Santos MS, Oliveira CR, Aliev G, Nunomura A, Zhu X, Smith MA, Perry G. Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Current Alzheimer Research. 2: 403-8. PMID 16248845 DOI: 10.2174/156720505774330537 |
0.837 |
|
| 2005 |
Aliyev A, Chen SG, Seyidova D, Smith MA, Perry G, de la Torre J, Aliev G. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. Journal of the Neurological Sciences. 229: 285-92. PMID 15760652 DOI: 10.1016/J.Jns.2004.11.040 |
0.714 |
|
| 2005 |
Moreira PI, Smith MA, Zhu X, Honda K, Lee HG, Aliev G, Perry G. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful? Drug News & Perspectives. 18: 13-9. PMID 15753972 DOI: 10.1358/Dnp.2005.18.1.877164 |
0.828 |
|
| 2005 |
Liu Q, Smith MA, Avilá J, DeBernardis J, Kansal M, Takeda A, Zhu X, Nunomura A, Honda K, Moreira PI, Oliveira CR, Santos MS, Shimohama S, Aliev G, de la Torre J, et al. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radical Biology & Medicine. 38: 746-54. PMID 15721985 DOI: 10.1016/J.Freeradbiomed.2004.11.005 |
0.81 |
|
| 2005 |
de la Torre JC, Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 663-72. PMID 15703700 DOI: 10.1038/sj.jcbfm.9600057 |
0.342 |
|
| 2005 |
Moreira PI, Siedlak SL, Aliev G, Zhu X, Cash AD, Smith MA, Perry G. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. Journal of Neural Transmission (Vienna, Austria : 1996). 112: 921-32. PMID 15583960 DOI: 10.1007/S00702-004-0242-8 |
0.818 |
|
| 2005 |
Moreira P, Honda K, Liu Q, Aliev G, Oliveira C, Santos M, Zhu X, Smith M, Perry G. Alzheimers Disease and Oxidative Stress: The Old Problem Remains Unsolved Current Medicinal Chemistry-Central Nervous System Agents. 5: 51-62. DOI: 10.2174/1568015053202714 |
0.828 |
|
| 2005 |
Aliev G, Perry G, Liu J, Smith MA, Chen SG, Ames BN, de la Torre JC. [P-074]: The primary pathogenetic role of vascular contains vasoactive substances, hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease Alzheimer's & Dementia. 1: S31-S31. DOI: 10.1016/J.Jalz.2005.06.148 |
0.689 |
|
| 2005 |
Moreira PI, Honda K, Liu Q, Aliev G, Oliveira CR, Santos MS, Zhu X, Smith MA, Perry G. Alzheimer's disease and oxidative stress: The old problem remains unsolved Current Medicinal Chemistry - Central Nervous System Agents. 5: 51-62. |
0.37 |
|
| 2004 |
Aliev G, Smith MA, de la Torre JC, Perry G. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion. 4: 649-63. PMID 16120422 DOI: 10.1016/j.mito.2004.07.018 |
0.722 |
|
| 2004 |
Aliev G, Castellani RJ, Petersen RB, Burnstock G, Perry G, Smith MA. Pathobiology of familial hypercholesterolemic atherosclerosis. Journal of Submicroscopic Cytology and Pathology. 36: 225-40. PMID 15906597 |
0.6 |
|
| 2004 |
Zhu X, Smith MA, Perry G, Aliev G. Mitochondrial failures in Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias. 19: 345-52. PMID 15633943 DOI: 10.1177/153331750401900611 |
0.729 |
|
| 2004 |
de la Torre J, Aliev G, Perry G. Drug therapy in Alzheimer's disease. The New England Journal of Medicine. 351: 1911-3; author reply. PMID 15509830 DOI: 10.1056/Nejm200410283511822 |
0.575 |
|
| 2004 |
Seyidova D, Aliyev A, Rzayev N, Obrenovich M, Lamb BT, Smith MA, de la Torre JC, Perry G, Aliev G. The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease. In Vivo (Athens, Greece). 18: 325-33. PMID 15341188 |
0.624 |
|
| 2004 |
Aliyev A, Seyidova D, Rzayev N, Obrenovich ME, Lamb BT, Chen SG, Smith MA, Perry G, de la Torre JC, Aliev G. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease? Neurological Research. 26: 547-53. PMID 15265272 DOI: 10.1179/01610425017613 |
0.667 |
|
| 2004 |
Casadesus G, Smith MA, Zhu X, Aliev G, Cash AD, Honda K, Petersen RB, Perry G. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. Journal of Alzheimer's Disease : Jad. 6: 165-9. PMID 15096700 DOI: 10.3233/Jad-2004-6208 |
0.831 |
|
| 2004 |
Aliev G, Siedlak SL, Smith MA, Aliyev A, Rzayev N, de la Torre JC, Perry G. O3-04-07 Vascular and metabolic failure in Alzheimer disease Neurobiology of Aging. 25: S61. DOI: 10.1016/S0197-4580(04)80204-5 |
0.623 |
|
| 2004 |
de la Torre JC, Aliev G. S3-04-02 Vascular nitric oxide: a key molecule in the pathogenesis of Alzheimer's disease? Neurobiology of Aging. 25: S50. DOI: 10.1016/S0197-4580(04)80170-2 |
0.46 |
|
| 2004 |
Aliev G, Seyidova D, Smith MA, Perry G, de la Torre JC. VASCULAR HYPOPERFUSION AND MITOCHONDRIA ABNORMALITY INDUCE OXIDATIVE STRESS THAT APPEARED TO BE A KEY FACTOR FOR THE DEVELOPMENT OF ALZHEIMER DISEASE Cardiovascular Pathology. 13: 26-27. DOI: 10.1016/j.carpath.2004.03.072 |
0.707 |
|
| 2003 |
Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotoxicity Research. 5: 491-504. PMID 14715433 DOI: 10.1007/Bf03033159 |
0.728 |
|
| 2003 |
Lee HG, Petersen RB, Zhu X, Honda K, Aliev G, Smith MA, Perry G. Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? Brain Pathology (Zurich, Switzerland). 13: 630-8. PMID 14655766 DOI: 10.1111/J.1750-3639.2003.Tb00491.X |
0.765 |
|
| 2003 |
Perry G, Nunomura A, Raina AK, Aliev G, Siedlak SL, Harris PL, Casadesus G, Petersen RB, Bligh-Glover W, Balraj E, Petot GJ, Smith MA. A metabolic basis for Alzheimer disease. Neurochemical Research. 28: 1549-52. PMID 14570400 DOI: 10.1023/A:1025678510480 |
0.801 |
|
| 2003 |
Aliev G, Seyidova D, Lamb BT, Obrenovich ME, Siedlak SL, Vinters HV, Friedland RP, LaManna JC, Smith MA, Perry G. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurological Research. 25: 665-74. PMID 14503022 DOI: 10.1179/016164103101201977 |
0.695 |
|
| 2003 |
Aliev G, Obrenovich ME, Smith MA, Perry G. Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease. Journal of Biomedicine & Biotechnology. 2003: 162-163. PMID 12975531 DOI: 10.1155/S1110724303305029 |
0.721 |
|
| 2003 |
Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, AvÃla J, Jones PK, Castellani RJ, Smith MA, et al. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. The American Journal of Pathology. 162: 1623-7. PMID 12707046 DOI: 10.1016/S0002-9440(10)64296-4 |
0.81 |
|
| 2003 |
Perry G, Ávila J, Casadesus G, Nunomura A, Tabaton M, Cash A, Aliev G, Wataya T, Shimohama S, Drew K, Atwoo C, Smith M. La función del estrés oxidativo en la patogénesis de la enfermedad de Alzheimer Revista Chilena De Neuro-PsiquiatríA. 41. DOI: 10.4067/S0717-92272003041200006 |
0.764 |
|
| 2003 |
Perry G, Ávila J, Casadesus G, Nunomura A, Tabaton M, Cash A, Aliev G, Wataya T, Shimohama S, Drew K, Atwood C, Smith M. The role of oxidative stress in the pathogenesis of Alzheimer's disease | La función del estrés oxidativo en la patogénesis de la enfermedad de Alzheimer Revista Chilena De Neuro-Psiquiatria. 41: 47-52. |
0.825 |
|
| 2002 |
Aliev G. Is non-genetic Alzheimer's disease a vascular disorder with neurodegenerative consequences? Journal of Alzheimer's Disease : Jad. 4: 513-6. PMID 12515902 DOI: 10.3233/Jad-2002-4607 |
0.403 |
|
| 2002 |
Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Annals of the New York Academy of Sciences. 977: 45-64. PMID 12480733 DOI: 10.1111/J.1749-6632.2002.Tb04798.X |
0.712 |
|
| 2002 |
Perry G, Nunomura A, Cash AD, Taddeo MA, Hirai K, Aliev G, Avila J, Wataya T, Shimohama S, Atwood CS, Smith MA. Reactive oxygen: its sources and significance in Alzheimer disease. Journal of Neural Transmission. Supplementum. 69-75. PMID 12456052 DOI: 10.1007/978-3-7091-6139-5_7 |
0.808 |
|
| 2002 |
Perry G, Nunomura A, Hirai K, Zhu X, Pérez M, Avila J, Castellani RJ, Atwood CS, Aliev G, Sayre LM, Takeda A, Smith MA. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radical Biology & Medicine. 33: 1475-9. PMID 12446204 DOI: 10.1016/S0891-5849(02)01113-9 |
0.849 |
|
| 2002 |
Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA. Role of mitochondrial dysfunction in Alzheimer's disease. Journal of Neuroscience Research. 70: 357-60. PMID 12391597 DOI: 10.1002/Jnr.10389 |
0.837 |
|
| 2002 |
Shi J, Perry G, Berridge MS, Aliev G, Siedlak SL, Smith MA, LaManna JC, Friedland RP. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 1044-51. PMID 12163630 |
0.671 |
|
| 2002 |
Aliev G, Smith MA, Seyidov D, Neal ML, Lamb BT, Nunomura A, Gasimov EK, Vinters HV, Perry G, LaManna JC, Friedland RP. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 12: 21-35. PMID 11770899 DOI: 10.1111/J.1750-3639.2002.Tb00419.X |
0.781 |
|
| 2001 |
Aliev G, Smith MA, Turmaine M, Neal ML, Zimina TV, Friedland RP, Perry G, LaManna JC, Burnstock G. Atherosclerotic lesions are associated with increased immunoreactivity for inducible nitric oxide synthase and endothelin-1 in thoracic aortic intimal cells of hyperlipidemic Watanabe rabbits. Experimental and Molecular Pathology. 71: 40-54. PMID 11502096 DOI: 10.1006/Exmp.2001.2380 |
0.643 |
|
| 2001 |
Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA. Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 60: 759-67. PMID 11487050 DOI: 10.1093/Jnen/60.8.759 |
0.838 |
|
| 2001 |
Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, et al. Mitochondrial abnormalities in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3017-23. PMID 11312286 |
0.848 |
|
| 2001 |
Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. Journal of Neurochemistry. 76: 435-41. PMID 11208906 DOI: 10.1046/J.1471-4159.2001.00046.X |
0.695 |
|
| 2001 |
Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PLR, Jones PK, et al. Mitochondrial Abnormalities in Alzheimer's Disease The Journal of Neuroscience. 21: 3017-3023. DOI: 10.1523/Jneurosci.21-09-03017.2001 |
0.846 |
|
| 2000 |
Aliev G, Shi J, Perry G, Friedland RP, Lamanna JC. Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of donryu rats on a cholesterol-enriched diet. The Anatomical Record. 260: 16-25. PMID 10967532 DOI: 10.1002/1097-0185(20000901)260:1<16::Aid-Ar20>3.0.Co;2-2 |
0.644 |
|
| 2000 |
Perry G, Nunomura A, Hirai K, Takeda A, Aliev G, Smith MA. Oxidative damage in Alzheimer's disease: the metabolic dimension. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 18: 417-21. PMID 10817925 DOI: 10.1016/S0736-5748(00)00006-X |
0.789 |
|
| 2000 |
Perry G, Hirai K, Aliev G, Nunomura A, Siedlak SL, Smith MA. Mitochondrial abnormalities in Alzheimer disease Neurobiology of Aging. 21: 213. DOI: 10.1016/S0197-4580(00)83289-3 |
0.773 |
|
| 2000 |
Aliev G, Shi J, LaManna JC, Lamb BT, Friedland RP. Atherosclerotic-like changes of the wall of cerebral microvessels in transgenic mice overexpressing amyloid β Neurobiology of Aging. 21: 267. DOI: 10.1016/S0197-4580(00)83155-3 |
0.531 |
|
| 2000 |
Aliev G, Shi J, LaManna JC, Friedland RP, Lamb BT. Mitochondrial abnormalities mark vulnerable neurons in APP YAC transgenic mice Neurobiology of Aging. 21: 267. DOI: 10.1016/S0197-4580(00)83153-X |
0.572 |
|
| 1999 |
Nunomura A, Perry G, Hirai K, Aliev G, Takeda A, Chiba S, Smith MA. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Annals of the New York Academy of Sciences. 893: 362-4. PMID 10672267 DOI: 10.1111/J.1749-6632.1999.Tb07855.X |
0.775 |
|
| 1999 |
Shi J, Perry G, Aliev G, Smith MA, Ashe KH, Friedland RP. Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model. Neuroreport. 10: 3229-32. PMID 10574565 DOI: 10.1097/00001756-199910190-00019 |
0.705 |
|
| 1998 |
Aliev G, Burnstock G. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis. Histology and Histopathology. 13: 797-817. PMID 9690137 DOI: 10.14670/Hh-13.797 |
0.33 |
|
| 1998 |
Aliev G, Bodin P, Burnstock G. Free radical generators cause changes in endothelial and inducible nitric oxide synthases and endothelin-1 immunoreactivity in endothelial cells from hyperlipidemic rabbits. Molecular Genetics and Metabolism. 63: 191-7. PMID 9608541 DOI: 10.1006/mgme.1997.2664 |
0.388 |
|
| Show low-probability matches. |
